BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11320715)

  • 1. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
    Klein N; Mende M; Hagendorff A; Neugebauer A; Pfeiffer D
    Dtsch Med Wochenschr; 2000 May; 125(19):579-83. PubMed ID: 11320715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F; Di Mario C; Catanoso A; Dharmadhikari A; Tzifos V; Anzuini A; Carlino M; Briguori C; Montorfano M; Vaghetti M; Tolaro S; Colombo A
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [One-year follow-up after echocardiographically-guided percutaneous septal ablation in hypertrophic obstructive cardiomyopathy].
    Seggewiss H; Faber L; Ziemssen P; Gleichmann U
    Dtsch Med Wochenschr; 2001 Apr; 126(15):424-30. PubMed ID: 11347004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H; Faber L
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
    Veselka J; Procházková S; Duchonová R; Bolomová-Homolová I; Pálenícková J; Tesar D; Cervinka P; Honek T
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):231-5. PubMed ID: 15390343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Percutaneous transluminal ablation of the myocardial septum by embolization of the first branch of the anterior descending coronary artery using a small amount of absolute alcohol].
    Miric M; Sagic D; Popovic Z; Zlatanovic M; Vlahovic A; Vidakovic R; Bojic M
    Srp Arh Celok Lek; 2001; 129(7-8):199-202. PubMed ID: 11797450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
    Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis.
    Alam M; Dokainish H; Lakkis NM
    Eur Heart J; 2009 May; 30(9):1080-7. PubMed ID: 19233857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
    Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
    Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocardial radiofrequency ablation of septal hypertrophy. A new catheter-based modality of gradient reduction in hypertrophic obstructive cardiomyopathy.
    Lawrenz T; Kuhn H
    Z Kardiol; 2004 Jun; 93(6):493-9. PubMed ID: 15252744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
    Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
    Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
    Veselka J
    Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
    J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment strategies for hypertrophic obstructive cardiomyopathy: alcohol ablation of the septum: the new gold standard?
    Hess OM; Sigwart U
    J Am Coll Cardiol; 2004 Nov; 44(10):2054-5. PubMed ID: 15542291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
    Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
    Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Catheter treatment of hypertrophic obstructive cardiomyopathy].
    Gleichmann U; Seggewiss H; Faber L; Fassbender D; Schmidt HK; Strick S
    Dtsch Med Wochenschr; 1996 May; 121(21):679-85. PubMed ID: 8646974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    van Dockum WG; Beek AM; ten Cate FJ; ten Berg JM; Bondarenko O; Götte MJ; Twisk JW; Hofman MB; Visser CA; van Rossum AC
    Circulation; 2005 May; 111(19):2503-8. PubMed ID: 15867172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?
    Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ
    J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.